Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
source: pixabay.com
Over the last two years, the COVID-19 pandemic has dominated the headlines. In 2021, vaccines became available to prevent severe COVID-19 infection. However, this has also brought up numerous questions…
Continue Reading
No Relationship Between COVID-19 Vaccine and Preterm Birth, Study Shares
In late December 2021, biopharmaceutical company Deciphera Pharmaceuticals, Inc. ("Deciphera") shared that its therapy QINLOCK (ripretinib) was approved in the United Kingdom. The treatment is designed for adults with advanced…
Continue Reading
ICYMI: QINLOCK Approved in UK for GISTs
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/
The Klassen family is no stranger to the rare disease community. According to the Denver Post, Greg Klassen was first diagnosed with spinocerebellar ataxia type 3 (SCA3) nearly ten years…
Continue Reading
Family Raises SCA3 Awareness
source: pixabay.com
A glioblastoma diagnosis can be devastating. Currently, the 5-year survival rate is under 10%. This highly malignant cancer, which forms in the brain and spinal cord, is also somewhat difficult…
Continue Reading
Could IL-7 Improve Glioblastoma Survival?
Grant and award programs can be crucial in spurring therapeutic discovery and development. According to News Medical, this is what the Follicular Lymphoma Foundation (FLF) aims to do with its…
Continue Reading
CURE FL Awards Program Offers Follicular Lymphoma Research Grants
source: pixabay.com
Recently, Chain Drug Review reported that the FDA had approved a generic form of colchicine pills (normally prescribed as Mitigare, Colcrys, or Gloperba) for the treatment of familial Mediterranean fever (FMF).…
Continue Reading
Generic Colchicine Tablets Now FDA-Approved for Familial Mediterranean Fever
source: pixabay.com
According to the Cancer Network, a CAR T-cell therapy called C-CAR039 recently earned both Fast Track and Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration.…
Continue Reading
C-CAR039 Earns RMAT, Fast Track Designations for DLBCL
source: pixabay.com
It's January -- do you know what that means? That's right - it's National Glaucoma Awareness Month! According to the Richmond Register, glaucoma diagnoses are rising on a national level.…
Continue Reading
It’s National Glaucoma Awareness Month!
Screenshot/Instagram: https://www.instagram.com/p/CYqNhVVsGpL/
On January 12, 2022, posts shared on Facebook and Instagram announced the passing of 15-year-old Adalia Rose Williams. A Youtube and Facebook star, Adalia had over 16 million followers collectively.…
Continue Reading
Social Media Star Adalia Rose Williams, Who Had Progeria, Has Passed Away
Crohn’s disease causes inflammation throughout the digestive tract. But what factors influence the severity of this inflammation? Medical XPress describes how a study out of Case Western Reserve University discovered…
Continue Reading
C. tropicalis Fungi Linked to Crohn’s Disease
source: pixabay.com
In the past, there have been little to no concrete studies evaluating the relationship between hereditary angioedema (HAE) and cancer risk. However, researchers questioned whether some sort of relationship could…
Continue Reading
Does HAE Predispose People to Cancer?
How does long-term non-steroidal anti-inflammatory drug (NSAID) use influence health? Do NSAIDS used by older adults influence the development of any other conditions or adverse reactions? According to the Nephrology…
Continue Reading
Do NSAIDs Increase Hyperkalemia Risk in Older Individuals?
source: pixabay.com
What if researchers could change DNA processes within brain tumors to improve overall survival rates and patient outcomes? According to Medical XPress, researchers found that L-methylfolate, in conjunction with the…
Continue Reading
L-methylfolate Changes Glioblastoma DNA Process
source: pixabay.com
Today, follow along on a case study exploration to see how a 52-year-old woman finally received a diagnosis of stiff person syndrome (SPS), a rare neurological disorder. According to the…
Continue Reading
The Diagnostic Journey to Stiff Person Syndrome (SPS)
Is there a relationship between increased sun exposure and breast cancer risk? At first glance, you might think, “Sure. Sun exposure probably increases the risk.” However, according to an article…
Continue Reading
The Relationship Between Sun Exposure and Breast Cancer
It’s no secret that stress can be both psychologically and physically damaging. But how does stress influence the way that our bodies respond to certain conditions? According to Medical XPress,…
Continue Reading
How Stress Contributes to Crohn’s Disease
https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/
When she was born, Savannha Aretino was diagnosed with hypophosphatasia, a rare genetic disorder characterized by bone and teeth development abnormalities. Now, twenty-three years later, Savannha is working to not…
Continue Reading
Graduate Raises Hypophosphatasia Awareness
source: pixabay.com
It’s January 2022 – have you checked on your thyroid health lately? If not, consider learning more about thyroid disease and what your thyroid does for the body. Why…
Continue Reading
January 2022: National Thyroid Awareness Month
source: pixabay.com
According to Healio, the U.S. Food and Drug Administration (FDA) recently granted Fast Track designation to LioCyx-M004. This therapy, developed by T-cell immunotherapy company Lion TCR, is designed to…
Continue Reading
LioCyx-M004 for HBV-Related Hepatocellular Carcinoma Earns Fast Track Designation
source: pixabay.com
In the European Union (EU), Orphan Drug designation is given to drugs or biologics intending to improve the treatment, diagnosis, or prevention of rare or serious illnesses. To be…
Continue Reading
Atrasentan for IgAN Earns Orphan Drug Status in EU
source: pixabay.com
In the United States, Orphan Drug designation is granted to drugs or biologics intended to treat, diagnose, or prevent rare diseases. For the purpose of this status, “rare” conditions…
Continue Reading
ADVM-062 for BCM Earns Orphan Drug Designation
https://unsplash.com/photos/Y14ONzYtxb4
Clinical trial results can help support drug developers' goals. For example, positive trial results may support Marketing Authorization Applications (MAAs) or other areas needed to get therapies into the…
Continue Reading
Positive MPOWERED Results Available on Mycapssa for Acromegaly
source: pixabay.com
The FDA grants Orphan Drug designation to drugs or biologics intended to treat, diagnose, or prevent rare diseases. For the purpose of this designation, "rare" conditions are those affecting…
Continue Reading
OM-301 for AML Granted Orphan Drug Designation
source: pixabay.com
Pursuing an education can be difficult enough without any other extraneous factors. But what if you were also battling frequent infections, gastrointestinal problems, and recurrent hospitalizations? For Evan Brandon,…
Continue Reading
INFILTR8: A New and Rare Genetic Disease
source: pixabay.com
Over the last 10+ years, there have been extreme advances in the treatment of metastatic melanoma. In particular, researchers have sought to develop therapies which halted cancer progression and reduced…
Continue Reading
Relatlimab + Nivolumab Increase Survival in Metastatic Melanoma